News

Virovek announces the appointment of Peter L. Hoang as CEO

Virovek, a commercial-stage biotechnology company specializing in the development, manufacturing and sale of custom-made AAV- and lentivirus-based vectors for therapeutic development, today announced that the Company has appointed Peter L. Hoang as its Chief Executive Officer.

read more

Virovek Online Store Beta Release

September 13, 2023. Virovek is launching an online storefront for premade product sales. Customers will now be able to add premade AAV to their carts with the click of a button, place their orders entirely online, and have their orders shipped to them anywhere in the...

read more

Virovek is hiring.

June 2023. Job Title: Jr. Research Associate Job ID#: JRA0608 Employer: Virovek, Inc. Worksite: 8300 Cypress Creek Pkwy., Suite 100, Houston, TX 77070 Responsibilities:  Perform Gene Cloning, Recombinant Baculovirus Generation, and AAV Vector Production; ...

read more

Virovek Now Delivers AAVs in HEK293 Cells

Hayward, California - March 10, 2021 Virovek is pleased to launch a new service line, producing adeno-associated virus (AAV) vector in human embryonic kidney HEK293 cells through three plasmid transfection method. See our HEK293 page for more details and inventory...

read more

Virovek launched a new product, BacEZ Titer Kit

Hayward, California, April 10, 2009 — Virovek announced today that it launched a new product, BacEZ Titer Kit, for baculovirus titration. This kit offers customer more reagents for lower cost as compared with other competitors’ similar product. It uses a standard...

read more

MIT will use Virovek’s AAV production technology

Hayward, California, January 7, 2009 — Virovek announced that it signed a licensing agreement with Massachusetts Institute of Technology (MIT) in which MIT will use Virovek’s AAV production technology for its neuroscience research in the viral core facility newly...

read more